Estimated economic benefits during the 'decade of vaccines' include treatment savings, gains in labor productivity

Meghan L. Stack, Sachiko Ozawa, David M. Bishai, Andrew Mirelman, Yvonne Tam, Louis Niessen, Damian G. Walker, Orin S. Levine

Research output: Contribution to journalArticlepeer-review

Abstract

In 2010 the Bill & Melinda Gates Foundation announced a $10 billion commitment over the next ten years to increase access to childhood vaccines in the world's poorest countries. The effort was labeled the "Decade of Vaccines." This study estimates both the short- and long-term economic benefits from the introduction and increased use of six vaccines in seventy-two of the world's poorest countries from 2011 to 2020. Increased rates of vaccination against pneumococcal and Haemophilus influenzae type b pneumonia and meningitis, rotavirus, pertussis, measles, and malaria over the next ten years would save 6.4 million lives and avert 426 million cases of illness, $6.2 billion in treatment costs, and $145 billion in productivity losses. Monetary estimates based on this type of analysis can be used to determine the return on investment in immunization from both the international community and local governments, and they should be considered in policy making.

Original languageEnglish (US)
Pages (from-to)1021-1028
Number of pages8
JournalHealth Affairs
Volume30
Issue number6
DOIs
StatePublished - Jun 2011

ASJC Scopus subject areas

  • Health Policy

Fingerprint Dive into the research topics of 'Estimated economic benefits during the 'decade of vaccines' include treatment savings, gains in labor productivity'. Together they form a unique fingerprint.

Cite this